Get the Daily Brief
Latest Biotech News
Innovative Drug Discovery and Biotech Financing Capture Industry Momentum
Concept Life Sciences expanded its integrated drug discovery facilities in the UK, consolidating chemistry, ADMET, and biology to accelerate early-stage research. This enhancement supports...
Radiation Oncology Innovations Highlighted at ASTRO 2025
Leading cancer centers presented breakthroughs in radiation oncology at the 2025 ASTRO meeting. UCLA and University of Cincinnati researchers unveiled advancements including targeted radioactive...
Novel Therapeutics and Molecular Mechanisms in Oncology and Rare Diseases
Recent research sheds light on molecular targets and novel treatments across oncology and rare diseases. UCLA scientists identified a protein IGF2BP3 that rewires leukemia metabolism and RNA...
Cell and Gene Therapy Developments: CRISPR and CAR T Advancements
Emerging cell and gene therapy innovations signal progress in treating diverse diseases. CRISPR-edited 'hypoimmune' pancreatic islet cells can now be transplanted without immunosuppression for...
Biotech Industry and Policy: Pricing Models and Market Access Tools
Policy and market dynamics are rapidly evolving in biotech. The U.S. Department of Health and Human Services submitted a proposed rule to introduce a Most-Favored-Nation (MFN) prescription drug...
Biotech Incubators and Startup Ecosystem Expansion
Eli Lilly has launched a new biotech incubator in San Diego, Gateway Labs, offering collaborative lab and office spaces with access to expertise aiming to foster innovation. The location spans...
Cutting-Edge Biomedical Sciences: Organisms, Vaccines, and Molecular Understanding
Diverse biomedical breakthroughs emerged across infectious disease, developmental biology, and neurodegenerative conditions. The University of the Sunshine Coast secured approval for the world’s...
Crinetics Gains FDA Nod for Oral Acromegaly Therapy, Challenges Established Drugs
Crinetics Pharmaceuticals secured FDA approval for Palsonify (paltusotine), marking its first authorized treatment targeting acromegaly, a rare endocrine disorder caused by excessive growth...
Eli Lilly’s Oral SERD Wins FDA Approval in Advanced Breast Cancer
The FDA authorized Eli Lilly's imlunestrant (Inluriyo), an oral selective estrogen receptor degrader, for treatment of adults with estrogen receptor-positive, HER2-negative advanced or metastatic...
Trump Administration Imposes 100% Tariffs on Imported Pharmaceuticals
President Donald Trump announced a 100% tariff on branded pharmaceutical imports effective October 1, with exemptions for companies building manufacturing plants in the U.S. This move aims to...
ARPA-H Launches Major Programs to Expand Access to Custom Gene Editing Therapies
The Advanced Research Projects Agency for Health (ARPA-H) unveiled two nine-figure funding initiatives: THRIVE and GIVE. THRIVE focuses on accelerating design platforms for personalized gene...
Bridge Recombinases Enable Megabase-Scale Programmable DNA Rearrangements
Scientists at the Arc Institute introduced an innovative gene-editing platform utilizing bridge recombinases, naturally occurring RNA-guided DNA-modifying enzymes, to rearrange large genomic...
UC Irvine Researchers Develop Pan-Cancer Immunotherapy Targeting Glycans
University of California, Irvine experts engineered glycan-dependent T cell recruiters (GlyTRs) that selectively bind tumor-associated carbohydrate antigens, enabling potent T cell-mediated...
Novel AI and Robotics Technologies Advance Cell Analysis and Clinical Predictions
Recent breakthroughs demonstrate AI-driven single-cell analysis via an AI-powered parallel microdevice facilitating high-throughput biomolecule delivery, alongside hypersonic levitation and...
Crinetics Pharmaceuticals’ Palsonify Approvals and Market Impact
Crinetics Pharmaceuticals’ Palsonify, approved by the FDA, offers a once-daily oral treatment for acromegaly patients ineligible for surgery or with inadequate surgical response. The therapy...
Eli Lilly Expands Biotech Collaboration with San Diego Incubator Site
Eli Lilly opened its Gateway Labs incubator site in San Diego’s Torrey Pines, offering 82,514 square feet of laboratory and office space to support early-stage biotech companies. The facility aims...
Crinetics leaps into acromegaly market with FDA greenlight: Faces established giants
Crinetics Pharmaceuticals secured FDA approval for Palsonify (paltusotine), the first oral first-line therapy for acromegaly patients inadequately served by surgery or ineligible for it. This...
Trump’s pharmaceutical tariffs put biotech in crosshairs: Implementation details emerge
The Trump administration announced a 100% tariff on branded drug imports starting October 1, sparking anxiety across the biotech sector. The tariff exempts generic drugs and companies actively...
Breakthrough gene editing technology enables mega-scale DNA rearrangements in human cells
Researchers at the Arc Institute developed and optimized bridge recombinase technology for human cells, allowing programmable megabase-scale chromosomal DNA rearrangements. This RNA-guided system...
AI-driven methods surging in diagnostics, clinical trials and oncology research
Artificial intelligence continues to transform diagnostics and therapeutics across biomedical fields. Studies demonstrate AI’s capacity to enhance single-cell analysis via hypersonic levitation,...